A Review of Factor VIII and Factor IX Assay Methods for Monitoring Extended Half-Life Products in Hemophilia A and B
Author:
Publisher
Springer US
Link
https://link.springer.com/content/pdf/10.1007/978-1-0716-3175-1_37
Reference35 articles.
1. Marlar RA, Strandberg K, Shima M et al (2020) Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B. Eur J Haematol 104:3–14. https://doi.org/10.1111/ejh.1333
2. Chhabra A, Spurden D, Fogarty PF et al (2020) Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B. Blood Coagul Fibrinolysis 31(3):186–192. https://doi.org/10.1097/MBC.0000000000000885
3. Ar MC, Balkan C, KavaklI K (2019) Extended half-life coagulation factors: a new era in the management of hemophilia patients. Turk J Hematol 36:141–154
4. Coyle TE, Reding MT, Lin JC et al (2014) Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. J Thromb Haemost 12:488–496. https://doi.org/10.1111/jth.12506
5. Brennan Y, Parikh S, McRae S et al (2020) The Australian experience with switching to extended half-life factor VIII and IX concentrates: on behalf of the Australian Haemophilia Centre Directors’ Organisation. Haemophilia 26:529–535. https://doi.org/10.1111/hae.13970
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Strategies for Performing Factor Assays in the Presence of Emicizumab or Other Novel/Emerging Hemostatic Agents;Seminars in Thrombosis and Hemostasis;2024-06-12
2. Classification of recombinant factor VIII products and implications for clinical practice: A systematic literature review;Haemophilia;2024-03-29
3. Neurological Complications Associated with Hereditary Bleeding Disorders;Current Neurology and Neuroscience Reports;2023-10-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3